MedPath

Use of Consent Language and Mode to Improve Interactive Voice Response Survey in Colombia and Uganda

Not Applicable
Completed
Conditions
Surveys and Questionnaires
Noncommunicable Diseases
Interventions
Other: Modified Introduction
Other: Active Opt-in
Other: Passive Opt-in
Other: Active Opt-out
Registration Number
NCT04394520
Lead Sponsor
Johns Hopkins Bloomberg School of Public Health
Brief Summary

This study evaluates the effect of one new form of introduction language and three new modes of providing consent on interactive voice response (IVR) survey cooperation, response, refusal and contact rates, as compared to control group, in Colombia and Uganda.

Detailed Description

Using random digit dialing (RDD) sampling technique, RDD participants will be randomized to one of five introduction and consent combinations and then have them complete noncommunicable disease risk factor survey with an additional module regarding their understanding of the survey and of its voluntariness. This mobile phone survey will be sent as an interactive voice response (IVR). In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; If you are female, press 2). This study will be conducted in both Colombia and Uganda.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3786
Inclusion Criteria
  • Access to a mobile phone
  • Greater or equal to 18 years of age
  • In Colombia, conversant in the Spanish language. In Uganda, conversant in Luo, Luganda, Runyakitara or English languages.
Exclusion Criteria
  • Less than 18 years of age

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Modified Intro, Active Opt-inModified IntroductionModified introductory language will be used, and the consent mode will be changed to active opt-in only.
Modified Intro, Active Opt-inActive Opt-inModified introductory language will be used, and the consent mode will be changed to active opt-in only.
Modified Intro, Passive Opt-inModified IntroductionModified introductory language will be used, and the consent mode will be changed to passive opt-in only.
Modified Intro, Passive Opt-inPassive Opt-inModified introductory language will be used, and the consent mode will be changed to passive opt-in only.
Modified Intro, Standard ConsentModified IntroductionModified introductory language will be used, but the consent structure (active opt-in and active opt-out) will remain the same.
Modified Intro, Active Opt-outActive Opt-outModified introductory language will be used, and the consent mode will be changed to active opt-out only.
Modified Intro, Active Opt-outModified IntroductionModified introductory language will be used, and the consent mode will be changed to active opt-out only.
Primary Outcome Measures
NameTimeMethod
Cooperation Rate #1Through study completion, an average of one month

As defined by American Association for Public Opinion Research, the number of complete interviews divided by the number of complete interviews, partial interviews, refusals and breakoffs.

Response Rate #4Through study completion, an average of one month

As defined by American Association for Public Opinion Research, the number of complete and partial interviews divided by the number of complete interviews, partial interviews, refusals, breakoffs and the estimated eligible proportion of unknowns.

Secondary Outcome Measures
NameTimeMethod
Refusal Rate #2Through study completion, an average of one month

As defined by American Association for Public Opinion Research, the number of refusals and breakoffs divided by the number of complete interviews, partial interviews, refusals, breakoffs and the estimated eligible proportion of unknowns.

Contact Rate #2Through study completion, an average of one month

As defined by American Association for Public Opinion Research, the number of complete and partial interviews, refusals and breakoffs divided by the number of complete interviews, partial interviews, refusals, breakoffs and the estimated eligible proportion of unknowns.

Trial Locations

Locations (2)

Instituto de Salud Publica Pontificia Universidad Javeriana

🇨🇴

Bogota, D.c., Colombia

Makerere University School of Public Health

🇺🇬

Kampala, Uganda

© Copyright 2025. All Rights Reserved by MedPath